Cigarette Smoking and Competing Risks for Fatal and Nonfatal Cardiovascular Disease Subtypes Across the Life Course

Background Cigarette smoking is significantly associated with premature death related and not related to cardiovascular disease (CVD). Whether risk associated with smoking is similar across CVD subtypes and how this translates into years of life lost is not known. Methods and Results We pooled and harmonized individual‐level data from 9 population‐based cohorts in the United States. All participants were free of clinical CVD at baseline with available data on current smoking status, covariates, and CVD outcomes. We examined the association between smoking status and total CVD and CVD subtypes, including fatal and nonfatal coronary heart disease, stroke, congestive heart failure, and other CVD deaths. We performed (1) modified Kaplan–Meier analysis to estimate long‐term risks, (2) adjusted competing Cox models to estimate joint cumulative risks for CVD or noncardiovascular death, and (3) Irwin’s restricted mean to estimate years lived free from and with CVD. Of 106 165 adults, 50.4% were women. Overall long‐term risks for CVD events were 46.0% (95% CI, 44.7–47.3) and 34.7% (95% CI, 33.3–36.0) in middle‐aged men and women, respectively. In middle‐aged men who reported smoking compared with those who did not smoke, competing hazard ratios (HRs) were higher for the first presentation being a fatal CVD event (HR, 1.79 [95% CI, 1.68–1.92]), with a similar pattern among women (HR,1.82 [95% CI, 1.68–1.98]). Smoking was associated with earlier CVD onset by 5.1 and 3.8 years in men and women. Similar patterns were observed in younger and older adults. Conclusions Current smoking was associated with a fatal event as the first manifestation of clinical CVD.

[1]  M. Cabana,et al.  Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.

[2]  Ahmed Jamal,et al.  Tobacco Product Use Among Adults — United States, 2019 , 2020, MMWR. Morbidity and mortality weekly report.

[3]  Alan D. Lopez,et al.  Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study , 2019, BMC Medicine.

[4]  Brian A. King,et al.  Tobacco Product Use Among Adults — United States, 2017 , 2018, MMWR. Morbidity and mortality weekly report.

[5]  Michael E. Hall,et al.  Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study , 2018, Circulation.

[6]  D. Lloyd‐Jones,et al.  Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity , 2018, JAMA cardiology.

[7]  C. Yancy,et al.  Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project. , 2016, JACC. Heart failure.

[8]  J. Manson,et al.  Risk Factors for Incident Hospitalized Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal Women , 2016, Circulation. Heart failure.

[9]  F. Speizer,et al.  Smoking and Mortality - Beyond Established Causes. , 2016, The New England journal of medicine.

[10]  A. Dyer,et al.  Data Resource Profile Data Resource Profile : The Cardiovascular Disease Lifetime Risk Pooling Project , 2015 .

[11]  Xin Xu,et al.  Annual healthcare spending attributable to cigarette smoking: an update. , 2015, American journal of preventive medicine.

[12]  Harry Hemingway,et al.  Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and implications for risk prediction , 2014, International journal of epidemiology.

[13]  Mark A Pereira,et al.  Smoking and risk of coronary heart disease in younger, middle-aged, and older adults. , 2014, American journal of public health.

[14]  R. D. de Boer,et al.  Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. , 2013, European heart journal.

[15]  Xuan Cai,et al.  Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project. , 2013, Journal of the American College of Cardiology.

[16]  M. Carnethon,et al.  Racial and ethnic residential segregation, the neighborhood socioeconomic environment, and obesity among Blacks and Mexican Americans. , 2013, American journal of epidemiology.

[17]  V. Beral,et al.  The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK , 2013, BDJ.

[18]  Lihui Zhao,et al.  Lifetime risk and years lived free of total cardiovascular disease. , 2012, JAMA.

[19]  K. Bibbins-Domingo,et al.  Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study. , 2012, American heart journal.

[20]  M. Burtscher Lifetime risks of cardiovascular disease. , 2012, The New England journal of medicine.

[21]  Ralph B D'Agostino,et al.  Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.

[22]  J. Murabito,et al.  Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.

[23]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[24]  T. Karrison,et al.  Use of Irwin's restricted mean as an index for comparing survival in different treatment groups--interpretation and power considerations. , 1997, Controlled clinical trials.

[25]  M Lunn,et al.  Applying Cox regression to competing risks. , 1995, Biometrics.